- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $141.75M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $141.75M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $35.61M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $23.51M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $80.28M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $80.91M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $229.49M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $236.28M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $187.75M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $188.35M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $788.42M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $793.08M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 170.51M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.48M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $12.86M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $553.98M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $545M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $22.77M |
| Net Income | Q1 2025 · Mar 31, 2024 | $4.77M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $11.58M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $36.46M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $54.35M |
| Revenue | Q1 2025 · Mar 31, 2024 | $90.81M |